Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

AIMS: We sought to conduct a meta-analysis to evaluate the efficacy and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with heart failure (HF) with preserved ejection fraction (HFpEF) and HF with mildly reduced ejection fraction (HFmrEF). METHODS: We searched the Cochrane L...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Huzaifa Ahmad, Shafiee, Arman, Athar, Mohammad Mobin Teymouri, Rafiei, Mohammad Ali, Mehmannavaz, Atefe, Jafarabady, Kyana, Shahid, Abia, Ahmad, Adeel, Ijaz, Sardar Hassan, Dani, Sourbha S., Minhas, Abdul Mannan Khan, Nashwan, Abdulqadir J., Fudim, Marat, Fonarow, Gregg C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602781/
https://www.ncbi.nlm.nih.gov/pubmed/37900570
http://dx.doi.org/10.3389/fcvm.2023.1273781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602781/
https://www.ncbi.nlm.nih.gov/pubmed/37900570
http://dx.doi.org/10.3389/fcvm.2023.1273781

Ejemplares similares